Professional Documents
Culture Documents
Genetic engineering
• Genetic modification/manipulation
1973
• Herbert Boyer and
Stanley Cohen
combine their
research to create
the first successful
recombinant DNA
organism
1974
• Rudolf Jaenisch
creates the world’s
first transgenic
animals
1976
• Genentech, the first genetic engineering company was
founded
1978
• Genentech announced the production of genetically
engineered human insulin1982
• After approval from the Food and Drug Administration, the
first genetically engineered drug hits the market
●
Stakeholder Theory AP
PL
●
Six Pillars of Character IC
AT
●
Transparency Issues IO
N PROS AND CONS OF
GENETIC ENGINEERING
Genetic Engineering
ACCOUNTING
FRAMEWORKS EFFECTS IN
●
Accounting for N ACCOUNTING
O
Biological Assets ATI TRANSACTIONS AND
IC
●
Accounting for PL
AP FINANCIAL REPORTING
Patents
●
Accounting
Legislations/
Regulations
Accounting Frameworks
Accounting Frameworks
Shareh
oldrs Investor
s
Six Pillars of Character
Trustworth
iness
●
Honesty: Truth about genetically made
products.
●
Integrity: Honoring their commitment
to give good service.
●
Reliability: Products work as intended.
●
Loyalty: Loyalty to consumers,
community, and employees first
before the company.
Six Pillars of Character
Disclosure
about…
●
Safety of their product
(certifications)
●
Processes done in their products
●
The implications to the
community and the environment
●
Issues faced by the products
(litigations)
PROS and CONS
PROS
• Informed
ConsentTruth
Telling
• Resource
Allocation
• Confidentiality
• Sanctity of Life
Effects on Accounting and Financial Reporting
PATENT LAW relating to GENETIC ENGINEERING
Chaturvedi, S. (n.d.). Patents and Biotechnology. Retrieved May 12, 2011, from Jurisnotes:
http://www.jurisnotes.com/IP/articles/patentsbio.htm
PATENT LAW relating to GENETIC ENGINEERING
Chaturvedi, S. (n.d.). Patents and Biotechnology. Retrieved May 12, 2011, from Jurisnotes:
http://www.jurisnotes.com/IP/articles/patentsbio.htm
PATENT LAW relating to GENETIC ENGINEERING
Australia USA
-the Australian Patent Act
-the US Patent Law
contained no prohibitions
against patenting of life forms declared living
except for human beings. organisms as inventable.
Chaturvedi, S. (n.d.). Patents and Biotechnology. Retrieved May 12, 2011, from Jurisnotes:
http://www.jurisnotes.com/IP/articles/patentsbio.htm
PATENT LAW relating to GENETIC ENGINEERING
Chaturvedi, S. (n.d.). Patents and Biotechnology. Retrieved May 12, 2011, from Jurisnotes:
http://www.jurisnotes.com/IP/articles/patentsbio.htm
PATENT LAW relating to GENETIC ENGINEERING
Europe India
-In its Legal protection of -In Indian patent act,
biotechnological inventions, inventability does not apply
it includes a non-exclusive list to plants and animals.
of non-patentable processes.
-’attack of obviousness’
Chaturvedi, S. (n.d.). Patents and Biotechnology. Retrieved May 12, 2011, from Jurisnotes:
http://www.jurisnotes.com/IP/articles/patentsbio.htm
PATENT LAW relating to GENETIC ENGINEERING
Center for food safety contributors. (n.d.). Genetic Engineering and Patents. Retrieved May 12, 2011, from Center for
Food Safety: http://www.centerforfoodsafety.org/campaign/save-our-seeds/genetic-engineering-and-patents/
PATENT LAW relating to GENETIC ENGINEERING
●
Entity controls the asset as a result of passt event
●
Probable that future economic benefits associated with
the asset will flow to the entity
●
Fair value or cost of the asset can be measured reliably
• Market price is
based on fair value
less cost to sell
• If there is no
existing market for
such product
compute for the
present value of all
future economic
benefits to be
derived from the
asset
• Cost
Fair Value
• As according to PAS 41
• Quoted price in the market
• Most recent market transaction price
• Market price for similar asset with
adjustment to reflect any differences
• Sector benchmark
• Present value of expected net cash flows
from the asset
Biological Assets Measurement
• Increasing market
share for products
• Accounting
standard for
reporting
• Cost
classification
• Cost
capitalization
• Costs of
technology
used
• Subsequent
valuation of
technologies
used.
Insufficient Legislation/Regulations
• Proposed Legislation
• require safety testing and labeling of GE crops.
• mandatory environmental impact statements
for every ecosystem into which any new GEO is
to be introduced
• Liability issues:
• responsible for the downstream effects of a
company's product, including damage to organic
producers and damage to the environment.